Management of Aspirin-Exacerbated Respiratory Disease: What Does the Future Hold?
Otolaryngol Clin North Am
; 57(2): 265-278, 2024 Apr.
Article
em En
| MEDLINE
| ID: mdl-37833102
ABSTRACT
Aspirin-exacerbated respiratory disease (AERD) is a subtype of chronic rhinosinusitis with polyps (CRSwNP) and asthma with higher recurrence of nasal polyps after surgery and severe asthma. Patients with CRSwNP and asthma should be screened for AERD by detailed history of aspirin/nonsteroidal anti-inflammatory drug reactions and review of medications that may mask aspirin reaction or directly by aspirin challenge. Treatment of AERD may require more intensive therapy, including endoscopic sinus surgery, daily aspirin therapy, leukotriene modifiers, or biologics.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Asma
/
Sinusite
/
Rinite
/
Pólipos Nasais
/
Asma Induzida por Aspirina
Limite:
Humans
Idioma:
En
Revista:
Otolaryngol Clin North Am
Ano de publicação:
2024
Tipo de documento:
Article